Literature DB >> 26659716

Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: comparison of different kits.

Elodie Rivière1, Bineta Ly2, Saida Boudaoud2, Houria Chavez2, Gaetane Nocturne1, Philippe Chanson3, Corinne Miceli Richard1, Xavier Mariette1.   

Abstract

Entities:  

Keywords:  Autoimmune Diseases; Cytokines; Sjøgren's Syndrome

Mesh：

Substances：

Year:  2015        PMID： 26659716     DOI： 10.1136/annrheumdis-2015-208557

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Emerging Roles of IL-33/ST2 Axis in Renal Diseases.

Authors:  Wei-Yu Chen; Lung-Chih Li; Jenq-Lin Yang
Journal:  Int J Mol Sci       Date:  2017-04-07       Impact factor: 5.923

2.  Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease.

Authors:  Dong Hyuk Seo; Xiumei Che; Min Seob Kwak; Soochan Kim; Jae Hyeon Kim; Hyun Woo Ma; Da Hye Kim; Tae Il Kim; Won Ho Kim; Seung Won Kim; Jae Hee Cheon
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

3.  Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis.

Authors:  Elodie Rivière; Jérémie Sellam; Juliette Pascaud; Philippe Ravaud; Jacques-Eric Gottenberg; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2018-06-08       Impact factor: 5.156

4.  Rapid systemic surge of IL-33 after severe human trauma: a prospective observational study.

Authors:  Olav Sundnes; William Ottestad; Guttorm Haraldsen; Torsten Eken; Camilla Schjalm; Peter Lundbäck; Lars la Cour Poulsen; Tom Eirik Mollnes
Journal:  Mol Med       Date:  2021-03-26       Impact factor: 6.354

5.  The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.

Authors:  Vikram Mehraj; Mohammad-Ali Jenabian; Rosalie Ponte; Bertrand Lebouché; Cecilia Costiniuk; Réjean Thomas; Jean-Guy Baril; Roger LeBlanc; Joseph Cox; Cécile Tremblay; Jean-Pierre Routy
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

6.  Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.

Authors:  Jérémie Sellam; Elodie Rivière; Alice Courties; Paul-Olivier Rouzaire; Barbara Tolusso; Edward M Vital; Paul Emery; Gianfranco Ferraccioli; Martin Soubrier; Bineta Ly; Houria Hendel Chavez; Yassine Taoufik; Maxime Dougados; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2016-12-13       Impact factor: 5.156
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.